AGREEMENT

Exhibit 10.12

with respect to investor relations services to be provided by Agency to China Children Pharmaceutical, Inc.

SERVICES.    China Children Pharmaceutical hereby engages Agency to provide investor relations services to China Children Pharmaceutical as of August 15, 2009 until December 15, 2010.  Unless written notification is received 30 days in advance, the Agreement is automatically renewable for one year.

TERM.   August 15, 2009 through December 31, 2010.

COMPENSATION.    Agency will receive compensation for its services hereunder in the amount 400,000 Warrants with Registration Rights with a $3.00 exercise price with piggy-back warrants attached with a $5.00 exercise price (FOUR HUNDRED THOUSAND WARRANTS WITH REGISTRATION RIGHTS) total warrants issuable at the closing of the acquisition or merger.  The warrants will be issuable at the closing of the merger approximately September 30, 2009.

EXPENSES.    During the Term, China Children Pharmaceutical will reimburse Agency for Agency’s actual, direct, out-of-pocket costs, for properly documented, verifiable, non-personal, reasonable business expenses incurred by Agency in connection with and directly relating to Agency’s performance of its services under this Agreement, such as long distance telephone charges, photocopies at a rate not to exceed $.10 per copy, newswire distribution, postage and miscellaneous expenses as necessary.  Expenses in excess of $500 shall be approved in writing by China Children Pharmaceutical in advance.

REPRESENTATIONS/WARRANTIES. Agency represents and warrants the following:

Any materials or documents submitted, developed or created by Agency for China Children Pharmaceutical shall not violate or infringe upon a trademark, trade name, copyright, patent, literary or any other property right of any person or entity or constitute defamation, libel, slander, trade disparagement, plagiarism or an invasion of privacy.

Agency has the right to enter int